ENG KOR
CONTACT
Prestige BiopharmaPrestige BiopharmaPrestige Biopharma
  • Our Company
    • About Us
    • R&D Centre
  • Our Science
    • First-in-Class Antibody
      • Overview
      • PBP1510
      • PBP1710
      • IDC001
    • Biosimilar
    • Vaccine
  • Investors
    • Stock Information
      • Listing Information
      • Stock Charts
    • Financial Information
      • Overview
      • Public Disclosures
      • Audited Financial Statements
      • Annual Report
  • Media
    • Press Release
    • Gallery
  • Careers


INVESTORS


Annual Report

Annual Report

DateTitle and Content
28.Sep.2022
Announcement

Announcement Title: Announcement of Financial Result
Date: 28-Sep-2022
Report: Audited Financial Statements - IFRS
Description: Full year result for the Financial Year Ending 30 June 2022


28.Sep.2022
Business Report FY2022 (01/07/2021-30/06/2022)
24.Sep.2021
Announcement

Announcement Title: Announcement of Financial Result
Date: 24-Sep-2021
Report: Audited Financial Statements - IFRS
Description: Full year result for the Financial Year Ending 30 June 2021


16.Sep.2021
Business Report FY2021 (01/07/2020-30/06/2021)
Connect with us on LinkedIn
Copyright © 2021 Prestige Biopharma Ltd. All Rights Reserved. Powered by: Web Design Singapore

Data Policy